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Sputum induction has recently been proposed as the only direct
noninvasive method for measuring airway inflammatory indices.
The reference values and the distribution of cells in induced spu-
tum in a control population have not yet been well defined. We
therefore evaluated data from a large number of healthy volun-
teers. One hundred fourteen healthy, nonatopic, nonsmoking vol-
unteers without airway hyperreactivity were enrolled (age: 38 
 
6
 
 13
yr [mean 
 
6
 
 SD]; FEV
 
1
 
: 105 
 
6
 
 10% predicted; provocative dose of
methacholine inducing a 20% decrease FEV
 
1
 
 
 
.
 
 3,200 
 
m
 
g). Ninety-
six subjects (84%) produced adequate analysis samples. The sub-
jects had a normal age distribution. Their induced sputum was rich
in macrophages (69.2 
 
6
 
 13%) and neutrophils (27.3 
 
6
 
 13%), and
poor in eosinophils (0.6 
 
6
 
 0.8%), lymphocytes (1.0 
 
6
 
 1.2%), and
epithelial cells (1.5 
 
6
 
 1.8%). Only macrophages and neutrophils
showed a normal distribution; total and differential counts of
other cells did not. We propose that these data be used in compar-
ison of the induced sputum cells of normal subjects and those of
patients with airway inflammation.
 
Sputum induction has recently been proposed as the only di-
rect noninvasive or relatively noninvasive method for measur-
ing airway inflammatory indices (1–3). In subjects with asthma
and/or chronic bronchitis, the numbers and types of cells
present in induced sputum differ from those in the sputum of
healthy subjects, suggesting that evaluation of induced sputum
may be a reproducible and valid technique in the management
of asthma and/or bronchitis (4–8).
Studies previously reported in the literature have included
small cohorts of subjects as referred to a control population.
The reference values and distribution of cells in induced spu-
tum in the general population are therefore not well defined.
Moreover, important aspects of induced-sputum cell counts
include not only the reference values, but also whether or not
the cell counts conform to a normal distribution. We evalu-
ated data from a large number of healthy volunteers in order
to determine these parameters in induced sputum.
 
METHODS
 
Study Population
 
One hundred-fourteen informed healthy volunteers underwent sputum
induction at the same time of the day. All subjects were nonsmokers
(lifetime never-smokers), were nonatopic (negative skin prick tests),
and had no history of asthma or other respiratory symptoms. Their
FEV
 
1
 
 was greater than 80% predicted, and their airway responsive-
ness to methacholine was normal (provocative dose of methacholine
producing a 20% decrease in FEV
 
1
 
 [PD
 
20
 
 methacholine] 
 
.
 
 3,200 
 
m
 
g).
No subjects had had reported symptoms of airway infections in the 3 mo
previous to the study.
 
Study Design
 
The subjects were studied for 3 d that fell within a 2-wk period. On
the first day the subjects were examined by means of a questionnaire
and skin prick tests with a range of antigens (dog hair, cat fur, 
 
Ambrosia
 
,
 
Betulacea
 
,
 
 Composite
 
,
 
 Graminacea
 
,
 
 Parietaria
 
,
 
 Salicacea Alternaria alter-
nata
 
,
 
 Oleacea
 
,
 
 Aspergillus fumigatus
 
,
 
 Cladosporium
 
,
 
 Dermatophagoides
pteronyssinus
 
,
 
 D. farinae
 
). On the second day, spirometry and methacho-
line inhalation tests were performed. On the third day, at least 1 wk after
the second visit, sputum was induced by inhalation of hypertonic saline.
The Ethics Committee of the Fondazione Salvatore Maugeri ap-
proved the study, and all volunteers gave written informed consent.
 
Methacholine Challenge
 
Methacholine (Sigma Chemical Co., St. Louis, MO) was dissolved in
distilled water and delivered by an ampule-dosimeter device (Mefar,
Brescia, Italy) driven by compressed air at a pressure of 1.5 kg/m
 
2
 
with 1-s activation and 5-s intervals between breaths. Aerosols were
inhaled during quiet tidal breathing. After inhalation of isotonic sa-
line as a control, subjects inhaled doubling doses of methacholine
from 20 to 3,200 
 
m
 
g. A 3-min interval was allowed before each dose
increment. FEV
 
1
 
 was measured 1 min after each dose, and the best of
three acceptable measurements was retained to create dose–response
curves. The noncumulative doses causing a 20% decrease in FEV
 
1
 
from control FEV
 
1
 
 (PD
 
20
 
 methacholine) were calculated by interpolation
between two adjacent points on the log dose–response curves.
 
Sputum Induction
 
Inhalation procedure.
 
 After baseline FEV
 
1
 
 and FVC measurements,
salbutamol was given by inhalation (200 
 
m
 
g by metered-dose inhaler),
and subjects inhaled hypertonic (4.5%) saline nebulized for periods of
progressively increasing length (1, 2, 4, 8, and 16 min). FEV
 
1
 
 was re-
measured 1 min after each inhalation period. An ultrasonic nebulizer
(DeVilbiss 65; DeVilbiss Corporation, Somerset, PA) was used to
nebulize the saline solutions.
 
Sputum processing.
 
 The collected sputum samples were examined
within 2 h. Selected portions of the sputum sample originating from
the lower respiratory tract were chosen through examination with an
inverted microscope, and were weighed. Dithiothreitol (DTT; Sputo-
lysin; Calbiochem Corp., San Diego, CA), freshly prepared in a 1:10
dilution with distilled water, was added in a volume (in microliters)
equal to four times the weight of the selected portion (in milligrams)
of each sputum specimen. The DTT–sputum mixture was placed in a
shaking water bath at 37
 
8
 
 C for 20 min and homogenized. It was further
diluted with phosphate buffered saline (PBS) in a volume equal to the
sputum plus DTT. The suspension was filtered through gauze to remove
mucus, and was centrifuged at 2,000 rpm for 5 min. The supernatant
was aspirated and frozen at 
 
2
 
70
 
8
 
C for later analysis. The cell pellet
 
(
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was resuspended in a volume of PBS equal to that of the sputum plus
DTT and PBS preparation described previously. Total cell count
(TCC) and viability (Trypan blue exclusion method) were determined
with a Burkers chamber hemocytometer. The cell suspension was
placed in a Shandon 3 cytocentrifuge (Shandon Southern Instruments,
Sewickley, PA) and cytospin preparations were made at 450 rpm for
6 min. Cytospin slides were fixed with methanol and were stained with
May–Grunwald–Giemsa for an overall differential cell count of 500
nucleated nonsquamous cells. Only samples with a cell viability 
 
.
 
 50%
and 
 
,
 
 20% squamous cell contamination were considered adequate.
 
Statistical Analysis
 
Results are expressed as mean 
 
6
 
 SD, and as the median with the in-
terquartile range. The cell count was displayed according to frequency
distributions expressed as percentages of total cells. We evaluated
whether the results were normally distributed. The goodness of fit to
the normal distribution was statistically assessed by using the Kolo-
mogorov–Smirnoff test.
 
RESULTS
 
Sputum induction was performed in all 114 subjects without
observing any significant adverse effect or a decrease of FEV
 
1
 
.
 
 20%. Induction was stopped in five subjects because of
general discomfort. Thirteen subjects did not produce adequate
sputum samples, and their expectorates were discharged. The
analysis of the distribution of different cells in sputum was
 
TABLE 1
DESCRIPTIVE STATISTICS AND KOLOMOGOROV–SMIRNOFF TEST RESULTS FOR
NORMALITY OF TOTAL AND DIFFERENTIAL CELL COUNTS IN INDUCED SPUTUM
 
Variable Mean 
 
6
 
 SD Median Minimum Maximum K-S d p Value*
Total cell count 
 
3
 
 10
 
6
 
/ml 2.7 
 
6
 
 2.5 1.8 0.4 14.2 0.200
 
,
 
 0.01
% Macrophages 69.2 
 
6
 
 13 69.0 40 95 0.063
 
.
 
 0.20*
% Neutrophils 27.3 
 
6
 
 13 28.5 2 49.2 0.077
 
.
 
 0.20*
% Eosinophils 0.6 
 
6
 
 0.8 0.2 0 2.4 0.256
 
,
 
 0.01
% Lymphocytes 1.0 
 
6
 
 1.2 0.8 0 5 0.211
 
,
 
 0.01
% Epithelial cells 1.5 
 
6
 
 1.8 1 0 8.2 0.196
 
,
 
 0.01
 
Definition of abbreviation
 
: K-S d 
 
5
 
 Kolomogorov–Smirnoff test results.
* p 
 
.
 
 0.05 signifies a significant goodness of fit.
Figure 1. Distribution of actual percentages of macrophages (top),
neutrophils (center), and eosinophils (bottom) in induced sputum in
comparison with the expected normal curve values for these cells.
Figure 2. Distribution of actual percentages of lymphocytes (top), epi-
thelial cells (center), and total cell count (bottom) in induced sputum in
comparison with the expected normal curve values.
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performed on 96 subjects (50 females and 46 males) who had
 
a normal age distribution
 
.
 
 Their induced sputum was rich in
macrophages (69.2 
 
6
 
 13% [mean 
 
6
 
 SD]; 1.79 
 
6
 
 1.50 
 
3
 
 10
 
6
 
cells/ml) and neutrophils (27.3 
 
6
 
 13%; 0.83 
 
6
 
 1.11 
 
3
 
 10
 
6
 
 cells/ml)
and poor in eosinophils (0.6 
 
6
 
 0.8%; 0.01 
 
6
 
 0.02 
 
3
 
 10
 
6
 
 cells/ml),
lymphocytes (1.0 
 
6
 
 1.2%; 0.03 
 
6
 
 0.07 
 
3
 
 10
 
6
 
 cells/ml), and epi-
thelial cells (1.5 
 
6
 
 1.8%; 0.04 
 
6
 
 0.07 
 
3
 
 10
 
6
 
 cells/ml) (Table 1).
Only macrophages and neutrophils showed a normal distribu-
tion; total and differential counts of other cells did not (Figures 1
and 2).
 
DISCUSSION
 
In order to utilize sputum induction analysis as a clinical and
research tool, it is necessary to determine the reference values
and distributions of cells on the basis of data from a large sam-
ple of healthy volunteers representative for age and sex of the
general population.
The mean values in our sample are in agreement with the
findings with other, smaller samples of healthy subjects in
which cellular analysis was based on selected sputum plugs (4,
9, 10–12). The induced sputum in our subjects was rich in mac-
rophages and neutrophils and poor in eosinophils, lympho-
cytes, and epithelial cells. Our data confirm a balance between
neutrophils and macrophages that may depend on the origins
of sputum specimens. It has, for example, been previously
shown that samples deriving from central airways tend to
present more neutrophils and fewer macrophages than do
samples from the more peripheral airways (12).
In our study, the percentage of eosinophils was never
higher than 2.4%. This finding may be useful both in clinical
practice and in research in order to define the lowest eosino-
phil percentage suggestive of a status of airway inflammation.
Our research confirms that lymphocytes are poorly repre-
sented in induced sputum; in fact, they were absent from most
of our samples. Moreover, our study confirms the importance
of considering epithelial cells in the differential cell count; al-
though they were absent from some samples, more than 5%
were present in others.
Our data indicate that in induced sputum, only macrophages
and neutrophils have a normal distribution. These findings
suggest that for eosinophils, lymphocytes, and epithelial cells,
nonparametric tests should be applied, since parametric ones
could result in a Type I error.
A limit of our study could be the applicability of our data to
other studies using a different sputum induction protocol in
terms of hypertonic saline concentration and duration of inha-
lation. However, a previous study found that sputum cell
counts were not affected by the tonicity of the saline used for
induction (13). Moreover, in our study only nine sputum sam-
ples were produced during the last step (16 min) of inhalation;
the other samples (93%) were produced during the first 15
min of inhalation. Considering that in other studies inhalation
lasted no more than 20 min, we believe that our data could
also be applicable to other studies with different durations of
inhalation. However, standardization of the duration of inha-
lation is recommended.
A second limitation of our study could be in the applicabil-
ity of the study data to other studies that use a different
method of sputum processing (e.g., entire expectorate). How-
ever, we have previously shown that there was no difference in
the differential cell count in a selected portion of sputum and
that in the entire expectorate produced by the same group of
healthy volunteers (8).
In conclusion, the present study provides reference values
and the distribution of cell counts in induced sputum from a
large sample of healthy volunteers. We propose that these
data be used in comparisons of induced sputum cell counts of
normal subjects with those of patients with airway inflammation.
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